Search

Your search keyword '"Huissoon, Aarnoud"' showing total 262 results

Search Constraints

Start Over You searched for: Author "Huissoon, Aarnoud" Remove constraint Author: "Huissoon, Aarnoud"
262 results on '"Huissoon, Aarnoud"'

Search Results

1. The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease

2. SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study

4. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

6. COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

8. Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations

11. Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans

12. Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes

14. British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders

15. Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease

16. Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists in the UK and Republic of Ireland

17. The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease

18. Case report: Clearance of longstanding, immune-deficiency-associated, vaccine-derived polio virus infection following remdesivir therapy for chronic SARS-CoV-2 infection

20. GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements

21. Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

25. Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension

26. Diagnostic application of patent blue V in sentinel lymph node biopsy for breast cancer - Is it time for a change?

27. Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology

28. The impact of anaphylaxis on the quality of life and mental health of adults

30. Increased seroprevalence and improved antibody responses following third primary SARS-CoV-2 immunisation: an update from the COV-AD study

31. Case report: Clearance of longstanding, immunedeficiency-associated, vaccinederived polio virus infection following remdesivir therapy for chronic SARS-CoV-2 infection.

32. Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK

33. SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings From The COV-AD Study

34. Whole-genome sequencing of patients with rare diseases in a national health system

35. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

36. The impact of anaphylaxis on the quality of life and mental health of adults.

37. Outcomes Following SARS-CoV-2 Infection in Patients With Primary and Secondary Immunodeficiency in The United Kingdom

38. Mutation in the TCRα subunit constant gene (TRAC) leads to a human immunodeficiency disorder characterized by a lack of [TCRαβ.sup.+] T cells

40. Long‐term safety and effectiveness of berotralstat for hereditary angioedema: The open‐label APeX‐S study

41. Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva

43. Publisher Correction:Whole-genome sequencing of a sporadic primary immunodeficiency cohort (Nature, (2020), 583, 7814, (90-95), 10.1038/s41586-020-2265-1)

44. Whole-genome sequencing of a sporadic primary immunodeficiency cohort

45. Long‐term safety and effectiveness of berotralstat for hereditary angioedema: The open‐label APeX‐S study

46. COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

47. Bayesian Inference Associates Rare KDR Variants With Specific Phenotypes in Pulmonary Arterial Hypertension

48. Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study.

50. Bi-allelic Loss-of-Function CACNA1B Mutations in Progressive Epilepsy-Dyskinesia

Catalog

Books, media, physical & digital resources